Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC (Moxiped)
Efficacy and Safety of Moxidectin-albendazole Combination for Trichuris Trichiura Infections in School-aged Children: a Double-blind Randomised Controlled Superiority Trial
Sponsor: Jennifer Keiser
This PHASE3 trial investigates Ascariasis and Hookworm Infections and is currently completed. Jennifer Keiser leads this study, which shows 8 recorded versions since 2024 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
8 versions recorded-
Oct 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Oct 2025 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 3 earlier versions
-
May 2024 — Jun 2024 [monthly]
Not Yet Recruiting PHASE3
-
Mar 2024 — May 2024 [monthly]
Not Yet Recruiting PHASE3
-
Feb 2024 — Mar 2024 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Jennifer Keiser
- Public Health Laboratory Ivo de Carneri
For direct contact, visit the study record on ClinicalTrials.gov .